nach oben

Journal of Nanoparticle Research

Erschienen in:

01.06.2022 | Review

Receptor-mediated cascade targeting strategies for the application to medical diagnoses and therapeutics of glioma

verfasst von: Man Liang, Juan Li, Leiqiang Han

Erschienen in: Journal of Nanoparticle Research | Ausgabe 6/2022

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Glioma is the most frequent tumor of the central nervous system with high morbidity and mortality. Despite the great progress to exploit diagnostic and therapeutic tools, the treatment of glioma remains a huge challenge. The special anatomical structure of the brain, in particular, the blood–brain barrier (BBB) and the blood–brain tumor barrier (BBTB), limits the drug delivery efficacy and causes the diagnosis and treatment failure of various drugs. This encourages researchers to develop some novel therapeutic strategies to address these problems. Currently, receptor-mediated cascade targeting (RMCT) strategies, with targeting ligands targeting BBB and BBTB simultaneously, have been developed to overcome the barriers and are expected to accurately deliver drugs to glioma for diagnosis and therapy. In this review, we summarize the receptors and targeting ligands used in glioma, the categories of RMCT strategies, and the nanoplatforms used in RMCT strategies. We believe that the RMCT strategies will provide a reference for glioma treatment in the clinic and improve the life quality of patients with glioma.

Vorheriger Artikel Systematic analysis of ferrofluid: a visualization review, advances engineering applications, and challenges

Nächster Artikel Research progress of photothermal-mediated immunotherapy in the prevention of tumor recurrence and metastases

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Ali ES, Sharker SM, Islam MT, Khan IN, Shaw S, Rahman MA et al (2021) Targeting cancer cells with nanotherapeutics and nanodiagnostics: current status and future perspectives. Semin Cancer Biol 69:52–68. https://doi.org/10.1016/j.semcancer.2020.01.011CrossRef

Altshuler DB, Kadiyala P, Nunez FJ, Nunez FM, Carney S, Alghamri MS et al (2020) Prospects of biological and synthetic pharmacotherapies for glioblastoma. Expert Opin Biol Ther 20:305–317. https://doi.org/10.1080/14712598.2020.1713085CrossRef

Banerjee K, Nunez FJ, Haase S, McClellan BL, Faisal SM, Carney SV et al (2021) Current approaches for glioma gene therapy and virotherapy. Front Mol Neurosci 14:621831. https://doi.org/10.3389/fnmol.2021.621831CrossRef

Bi YK, Liu LS, Lu YF, Sun T, Shen C, Chen XL et al (2016) T7 peptide-functionalized PEG-PLGA micelles loaded with carmustine for targeting therapy of glioma. Acs Appl Mater Inter 8:27465–27473. https://doi.org/10.1021/acsami.6b05572CrossRef

Bi JF, Chowdhry S, Wu SH, Zhang WJ, Masui K, Mischel PS (2020) Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets. Nat Rev Cancer 20:57–70. https://doi.org/10.1038/s41568-019-0226-5CrossRef

Bonnin DAA, Ran C, Havrda MC, Liu H, Hitoshi Y, Zhang ZH et al (2017) Insulin-mediated signaling facilitates resistance to PDGFR inhibition in proneural hPDGFB-driven gliomas. Mol Cancer Ther 16:705–716. https://doi.org/10.1158/1535-7163.MCT-16-0616CrossRef

Byeon HJ, le Thao Q, Lee S, Min SY, Lee ES, Shin BS et al (2016) Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society 225:301–313. https://doi.org/10.1016/j.jconrel.2016.01.046CrossRef

Carpenter AB, Carpenter AM, Aiken R, Hanft S (2021) Oncolytic virus in gliomas: a review of human clinical investigations. Ann Oncol 32:968–982. https://doi.org/10.1016/j.annonc.2021.03.197CrossRef

Chai ZL, Hu XF, Wei XL, Zhan CY, Lu LW, Jiang K et al (2017) A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. J Control Release 264:102–111. https://doi.org/10.1016/j.jconrel.2017.08.027CrossRef

Chen CT, Duan ZQ, Yuan Y, Li RX, Pang L, Liang JM et al (2017) Peptide-22 and cyclic RGD functionalized liposomes for glioma targeting drug delivery overcoming BBB and BBTB. Acs Appl Mater Inter 9:5864–5873. https://doi.org/10.1021/acsami.6b15831CrossRef

Chen L, Zeng D, Xu N, Li CP, Zhang WY, Zhu XJ et al (2019) Blood-brain barrier- and blood-brain tumor barrier-penetrating peptide-derived targeted therapeutics for glioma and malignant tumor brain metastases. Acs Appl Mater Inter 11:41889–41897. https://doi.org/10.1021/acsami.9b14046CrossRef

Chen JH, Ma YC, Du W, Dai TY, Wang YF, Jiang W et al (2020) Furin-instructed intracellular gold nanoparticle aggregation for tumor photothermal therapy. Adv Funct Mater 30:2001566. https://doi.org/10.1002/Adfm.202001566CrossRef

Choudhury H, Pandey M, Chin PX, Phang YL, Cheah JY, Ooi SC et al (2018) Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends. Drug Deliv Transl Re 8:1545–1563. https://doi.org/10.1007/s13346-018-0552-2CrossRef

Christie C, Madsen SJ, Peng Q, Hirschberg H (2015) Macrophages as nanoparticle delivery vectors for photothermal therapy of brain tumors. Ther Deliv 6:371–384. https://doi.org/10.4155/Tde.14.121CrossRef

Clarke MR, Jones B, Squires CLM, Imhoff FM, Harwood DT, Rhodes L et al (2021) Cyclic imine pinnatoxin G is cytotoxic to cancer cell lines via nicotinic acetylcholine receptor-driven classical apoptosis. J Nat Prod 84:2035–2042. https://doi.org/10.1021/acs.jnatprod.1c00418CrossRef

Cooney T, Yeo KK, Kline C, Prados M, Haas-Kogan D, Chi S et al (2020) Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma. Neuro-Oncol Pract 7:4–10. https://doi.org/10.1093/nop/npz033CrossRef

Cui Y, Zhang M, Zeng F, Jin H, Xu Q, Huang Y (2016) Dual-targeting magnetic PLGA nanoparticles for codelivery of paclitaxel and curcumin for brain tumor therapy. ACS Appl Mater Interfaces 8:32159–32169. https://doi.org/10.1021/acsami.6b10175CrossRef

Cui YX, Sun JJ, Hao WY, Chen MY, Wang YZ, Xu FH et al (2020) Dual-target peptide-modified erythrocyte membrane-enveloped PLGA nanoparticles for the treatment of glioma. Front Oncol 10:563938. https://doi.org/10.3389/Fonc.2020.563938CrossRef

Dai TC, Jiang K, Lu WY (2018) Liposomes and lipid disks traverse the BBB and BBTB as intact forms as revealed by two-step Forster resonance energy transfer imaging. Acta Pharm Sin B 8:261–271. https://doi.org/10.1016/j.apsb.2018.01.004CrossRef

de Araujo RV, Santos SD, Ferreira EI, Giarolla J (2018) New advances in general biomedical applications of PAMAM dendrimers. Molecules 23:2849. https://doi.org/10.3390/Molecules23112849CrossRef

di Polidoro AC, Zambito G, Haeck J, Mezzanotte L, Lamfers M, Netti PA et al (2021) Theranostic design of Angiopep-2 conjugated hyaluronic acid nanoparticles (Thera-ANG-cHANPs) for dual targeting and boosted imaging of glioma cells. Cancers 13:503. https://doi.org/10.3390/Cancers13030503CrossRef

Dong CY, Hong S, Zheng DW, Huang QX, Liu FS, Zhong ZL et al (2021) Multifunctionalized gold sub-nanometer particles for sensitizing radiotherapy against glioblastoma. Small 17:2006582. https://doi.org/10.1002/Smll.202006582CrossRef

Du CJ, Liu XP, Hu H, Li HM, Yu LD, Geng DY et al (2020) Dual-targeting and excretable ultrasmall SPIONs for T-1-weighted positive MR imaging of intracranial glioblastoma cells by targeting the lipoprotein receptor-related protein. J Mater Chem B 8:2296–2306. https://doi.org/10.1039/c9tb02391gCrossRef

Ekkelenkamp AE, Elzes MR, Engbersen JFJ, Paulusse JMJ (2018) Responsive crosslinked polymer nanogels for imaging and therapeutics delivery. J Mater Chem B 6:210–235. https://doi.org/10.1039/c7tb02239eCrossRef

Fang F, Zou D, Wang W, Yin Y, Yin T, Hao S et al (2017) Non-invasive approaches for drug delivery to the brain based on the receptor mediated transport. Mater Sci Eng, C Mater Biol Appl 76:1316–1327. https://doi.org/10.1016/j.msec.2017.02.056CrossRef

Fu SY, Liang M, Wang YL, Cui L, Gao CH, Chu XY et al (2019a) Dual-modified novel biomimetic nanocarriers improve targeting and therapeutic efficacy in glioma. Acs Appl Mater Inter 11:1841–1854. https://doi.org/10.1021/acsami.8b18664CrossRef

Fu QY, Zhao Y, Yang ZZ, Yue QM, Xiao WJ, Chen Y et al (2019) Liposomes actively recognizing the glucose transporter GLUT(1) and integrin alpha(v)beta(3) for dual-targeting of glioma. Arch Pharm 352:e1800219. https://doi.org/10.1002/ardp.201800219CrossRef

Gao H (2016) Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharmaceutica Sinica B 6:268–286. https://doi.org/10.1016/j.apsb.2016.05.013CrossRef

Gao JQ, Lv Q, Li LM, Tang XJ, Li FZ, Hu YL et al (2013) Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes. Biomaterials 34:5628–5639. https://doi.org/10.1016/j.biomaterials.2013.03.097CrossRef

Gao HL, Yang Z, Zhang S, Pang ZQ, Liu QF, Jiang XG (2014) Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays. Acta Biomater 10:858–867. https://doi.org/10.1016/j.actbio.2013.11.003CrossRef

Grimaudo MA, Concheiro A, Alvarez-Lorenzo C (2019) Nanogels for regenerative medicine. J Control Release 313:148–160. https://doi.org/10.1016/j.jconrel.2019.09.015CrossRef

Gu J, Al-Bayati K, Ho EA (2017) Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes. Drug Deliv Transl Res 7:497–506. https://doi.org/10.1007/s13346-017-0368-5CrossRef

Hajebi S, Rabiee N, Bagherzadeh M, Ahmadi S, Rabiee M, Roghani-Mamaqani H et al (2019) Stimulus-responsive polymeric nanogels as smart drug delivery systems. Acta Biomater 92:1–18. https://doi.org/10.1016/j.actbio.2019.05.018CrossRef

Hampton T (2015) Targeting insulin pathways to treat brain tumors. Jama-J Am Med Assoc 313:2114. https://doi.org/10.1001/jama.2015.5140CrossRef

Han LA, Li JF, Huang SX, Huang RQ, Liu SH, Hu X et al (2011) Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent. Biomaterials 32:2989–2998. https://doi.org/10.1016/j.biomaterials.2011.01.005CrossRef

Han SP, Zheng HY, Lu YP, Sun Y, Huang AH, Fei WD et al (2018) A novel synergetic targeting strategy for glioma therapy employing borneol combination with angiopep-2-modified, DOX-loaded PAMAM dendrimer. J Drug Target 26:86–94. https://doi.org/10.1080/1061186X.2017.1344849CrossRef

Hashimoto Y, Mukai S, Sasaki Y, Akiyoshi K (2018) Nanogel tectonics for tissue engineering: protein delivery systems with nanogel chaperones. Adv Healthc Mater 7:1800729. https://doi.org/10.1002/Adhm.201800729CrossRef

Hassan HAFM, Diebold SS, Smyth LA, Walters AA, Lombardi G, Al-Jamal KT (2019) Application of carbon nanotubes in cancer vaccines: achievements, challenges and chances. J Control Release 297:79–90. https://doi.org/10.1016/j.jconrel.2019.01.017CrossRef

Ho BN, Pfeffer CM, Singh ATK (2017) Update on nanotechnology-based drug delivery systems in cancer treatment. Anticancer res 37:5975–81. https://doi.org/10.21873/anticanres.12044CrossRef

Huang W, Liang YW, Sang CC, Mei CM, Li XL, Chen TF (2018) Therapeutic nanosystems co-deliver anticancer drugs and oncogene SiRNA to achieve synergetic precise cancer chemo-gene therapy. Journal of Materials Chemistry B 6:3013–3022. https://doi.org/10.1039/c8tb00004bCrossRef

Jang B, Kwon H, Katila P, Lee SJ, Lee H (2016) Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies. Adv Drug Deliver Rev 98:113–133. https://doi.org/10.1016/j.addr.2015.10.023CrossRef

Jhaveri A, Deshpande P, Pattni B, Torchilin V (2018) Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma. J Control Release 277:89–101. https://doi.org/10.1016/j.jconrel.2018.03.006CrossRef

Jiang Y, Yang WJ, Zhang J, Meng FH, Zhong ZY (2018) Protein toxin chaperoned by LRP-1-targeted virus-mimicking vesicles induces high-efficiency glioblastoma therapy in vivo. Adv Mater 30:1800316. https://doi.org/10.1002/Adma.201800316CrossRef

Jiao XX, Yu Y, Meng JX, He M, Zhang CJ, Geng WQ et al (2019) Dual-targeting and microenvironment-responsive micelles as a gene delivery system to improve the sensitivity of glioma to radiotherapy. Acta Pharm Sin B 9:381–396. https://doi.org/10.1016/j.apsb.2018.12.001CrossRef

Kadari A, Pooja D, Gora RH, Gudem S, Kolapalli VRM, Kulhari H et al (2018) Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy. Eur J Pharm Biopharm 132:168–179. https://doi.org/10.1016/j.ejpb.2018.09.012CrossRef

Kang T, Jiang MY, Jiang D, Feng XY, Yao JH, Song QX et al (2015) Enhancing glioblastoma-specific penetration by functionalization of nanoparticles with an iron-mimic peptide targeting transferrin/transferrin receptor complex. Mol Pharmaceut 12:2947–2961. https://doi.org/10.1021/acs.molpharmaceut.5b00222CrossRef

Kang SM, Duan WJ, Zhang SQ, Chen DW, Feng JF, Qi N (2020) Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma. Theranostics 10:4308–4322. https://doi.org/10.7150/thno.41322CrossRef

Kim JE, Patel MA, Mangraviti A, Kim ES, Theodros D, Velarde E et al (2017) Combination therapy with anti-PD-1, anti-TIM-3, and focal radiation results in regression of murine gliomas. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 23:124–136. https://doi.org/10.1158/1078-0432.CCR-15-1535CrossRef

Kim JS, Shin DH, Kim JS (2018) Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells. J Control Release 269:245–257. https://doi.org/10.1016/j.jconrel.2017.11.026CrossRef

Kobayashi H, Watanabe R, Choyke PL (2013) Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics 4:81–89. https://doi.org/10.7150/thno.7193CrossRef

Kuche K, Maheshwari R, Tambe V, Mak KK, Jogi H, Raval N et al (2018) Carbon nanotubes (CNTs) based advanced dermal therapeutics: current trends and future potential. Nanoscale 10:8911–8937. https://doi.org/10.1039/c8nr01383gCrossRef

Kuo YC, Lee CH (2016) Dual targeting of solid lipid nanoparticles grafted with 83–14 MAb and anti-EGF receptor for malignant brain tumor therapy. Life Sci 146:222–231. https://doi.org/10.1016/j.lfs.2016.01.025CrossRef

Lam FC, Morton SW, Wyckoff J, Han TLV, Hwang MK, Maffa A et al (2018) Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles. Nat Commun 9:1991. https://doi.org/10.1038/S41467-018-04315-4CrossRef

Large DE, Abdelmessih RG, Fink EA, Auguste DT (2021) Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliver Rev 176:113851. https://doi.org/10.1016/J.Addr.2021.113851CrossRef

Leng ZH, Zhuang QF, Li YC, He Z, Chen Z, Huang SP et al (2013) Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate. Carbohyd Polym 98:1173–1178. https://doi.org/10.1016/j.carbpol.2013.07.021CrossRef

Li HM, Tong YN, Bai L, Ye L, Zhong L, Duan XM et al (2018a) Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma. Int J Biol Macromol 107:204–211. https://doi.org/10.1016/j.ijbiomac.2017.08.155CrossRef

Li M, Shi KR, Tang X, Wei JJ, Cun XL, Long Y et al (2018b) Synergistic tumor microenvironment targeting and blood-brain barrier penetration via a pH-responsive dual-ligand strategy for enhanced breast cancer and brain metastasis therapy. Nanomed-Nanotechnol 14:1833–1843. https://doi.org/10.1016/j.nano.2018.05.008CrossRef

Li J, Liang HM, Liu J, Wang ZY (2018c) Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy. Int J Pharmaceut 546:215–225. https://doi.org/10.1016/j.ijpharm.2018.05.045CrossRef

Li GM, Wang JH, Xu M, Zhang HX, Tu CG, Yang JB et al (2020) Engineered exosome for NIR-triggered drug delivery and superior synergistic chemo-phototherapy in a glioma model. Appl Mater Today 20:100723. https://doi.org/10.1016/J.Apmt.2020.100723CrossRef

Liang M, Gao CH, Wang YL, Gong W, Fu SY, Cui L et al (2018) Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles. Drug Deliv 25:1652–1663. https://doi.org/10.1080/10717544.2018.1494223CrossRef

Liang S, Liu Y, Gao T, Liu XQ, Zhang ZP, Mu WW, et al. (2021) An integrated nanoaircraft carrier modulating antitumor immunity to enhance immune checkpoint blockade therapy. Adv Funct Mater. Artn 2106123 https://doi.org/10.1002/Adfm.202106123

Liu YJ, Yang Z, Huang XL, Yu GC, Wang S, Zhou ZJ et al (2018a) Glutathione-responsive self-assembled magnetic gold nanowreath for enhanced tumor imaging and imaging-guided photothermal therapy. ACS Nano 12:8129–8137. https://doi.org/10.1021/acsnano.8b02980CrossRef

Liu DZ, Cheng Y, Cai RQ, Wang WW, Cui H, Liu M et al (2018b) The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle. Nanomed-Nanotechnol 14:991–1003. https://doi.org/10.1016/j.nano.2018.01.004CrossRef

Liu YY, Zheng M, Jiao MZ, Yan CN, Xu S, Du QL et al (2021) Polymeric nanoparticle mediated inhibition of miR-21 with enhanced miR-124 expression for combinatorial glioblastoma therapy. Biomaterials 276:121036. https://doi.org/10.1016/j.biomaterials.2021.121036CrossRef

Liu XG, Duan YK, Hu DH, Wu M, Chen CJ, Ghode PB et al (2021b) Targeted photoacoustic imaging of brain tumor mediated by neutrophils engineered with lipid-based molecular probe. Acs Mater Lett 3:1284–1290. https://doi.org/10.1021/acsmaterialslett.1c00329CrossRef

Loh KP, Ho D, Chiu GNC, Leong DT, Pastorin G, Chow EK (2018) Clinical applications of carbon nanomaterials in diagnostics and therapy. Adv Mater 30:e1802368. https://doi.org/10.1002/adma.201802368CrossRef

Lu F, Pang Z, Zhao J, Jin K, Li H, Pang Q et al (2017) Angiopep-2-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats. Int J Nanomed 12:2117–2127. https://doi.org/10.2147/IJN.S123422CrossRef

Luo MH, Lewik G, Ratcliffe JC, Choi CHJ, Makila E, Tong WY et al (2019) Systematic evaluation of transferrin-modified porous silicon nanoparticles for targeted delivery of doxorubicin to glioblastoma. Acs Appl Mater Inter 11:33637–33649. https://doi.org/10.1021/acsami.9b10787CrossRef

Luther DC, Huang R, Jeon T, Zhang XZ, Lee YW, Nagaraj H et al (2020) Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles. Adv Drug Deliver Rev 156:188–213. https://doi.org/10.1016/j.addr.2020.06.020CrossRef

Lv LY, Li XR, Qian W, Li SN, Jiang Y, Xiong YK et al (2020) Enhanced anti-glioma efficacy by borneol combined with CGKRK-modified paclitaxel self-assembled redox-sensitive nanoparticles. Front Pharmacol 11:558. https://doi.org/10.3389/Fphar.2020.00558CrossRef

Majumder J, Taratula O, Minko T (2019) Nanocarrier-based systems for targeted and site specific therapeutic delivery. Adv Drug Deliver Rev 144:57–77. https://doi.org/10.1016/j.addr.2019.07.010CrossRef

Mignani S, Shi XY, Cena V, Rodrigues J, Tomas H, Majoral JP (2021) Engineered non-invasive functionalized dendrimer/dendron-entrapped/complexed gold nanoparticles as a novel class of theranostic (radio) pharmaceuticals in cancer therapy. J Control Release 332:346–366. https://doi.org/10.1016/j.jconrel.2021.03.003CrossRef

Minaei SE, Khoei S, Khoee S, Karimi MR (2019) Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma. Int J Biochem Cell B 108:72–83. https://doi.org/10.1016/j.biocel.2019.01.010CrossRef

Newton HB (2006) Advances in strategies to improve drug delivery to brain tumors. Expert Rev Neurother 6:1495–1509. https://doi.org/10.1586/14737175.6.10.1495CrossRef

Ni XR, Zhao YY, Cai HP, Yu ZH, Wang J, Chen FR et al (2020) Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models. J Neuro-Oncol 148:245–258. https://doi.org/10.1007/s11060-020-03527-3CrossRef

Niu JX, Wang LY, Yuan M, Zhang JX, Chen H, Zhang YS (2020) Dual-targeting nanocarrier based on glucose and folic acid functionalized pluronic P105 polymeric micelles for enhanced brain distribution. J Drug Deliv Sci Tec 57:101343. https://doi.org/10.1016/J.Jddst.2019.101343CrossRef

Pang ZQ, Gao HL, Yu Y, Chen J, Guo LR, Ren JF et al (2011) Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes. Int J Pharmaceut 415:284–292. https://doi.org/10.1016/j.ijpharm.2011.05.063CrossRef

Patil SS, Shinde VS, Misra RDK (2018) pH and reduction dual-stimuli-responsive PEGDA/PAMAM injectable network hydrogels via aza-michael addition for anticancer drug delivery. J Polym Sci Pol Chem 56:2080–2095. https://doi.org/10.1002/pola.29168CrossRef

Pavitra E, Dariya B, Srivani G, Kang SM, Alam A, Sudhir PR et al (2021) Engineered nanoparticles for imaging and drug delivery in colorectal cancer. Semin Cancer Biol 69:293–306. https://doi.org/10.1016/j.semcancer.2019.06.017CrossRef

Peng Y, Huang J, Xiao H, Wu T, Shuai X (2018) Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment. Int J Nanomed 13:3467–3480. https://doi.org/10.2147/IJN.S164611CrossRef

Pucci S, Fasoli F, Moretti M, Benfante R, Di Lascio S, Viani P et al (2021) Choline and nicotine increase glioblastoma cell proliferation by binding and activating alpha 7-and alpha 9-containing nicotinic receptors. Pharmacol Res 163:105336. https://doi.org/10.1016/J.Phrs.2020.105336CrossRef

Qi Y, Liu B, Sun Q, Xiong X, Chen Q (2020) Immune checkpoint targeted therapy in glioma: status and hopes. Front Immunol 11:578877. https://doi.org/10.3389/fimmu.2020.578877CrossRef

Ramalho MJ, Bravo M, Loureiro JA, Lima J, Pereira MC (2022) Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells. Life Sci 296:120435. https://doi.org/10.1016/j.lfs.2022.120435CrossRef

Raphey VR, Henna TK, Nivitha KP, Mufeedha P, Sabu C, Pramod K (2019) Advanced biomedical applications of carbon nanotube. Mat Sci Eng C-Mater 100:616–630. https://doi.org/10.1016/j.msec.2019.03.043CrossRef

Ren J, Shen S, Wang D, Xi Z, Guo L, Pang Z et al (2012) The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Biomaterials 33:3324–3333. https://doi.org/10.1016/j.biomaterials.2012.01.025CrossRef

Ruan SB, Xiao W, Hu C, Zhang HJ, Rao JD, Wang SH et al (2017) Ligand-mediated and enzyme-directed precise targeting and retention for the enhanced treatment of glioblastoma. Acs Appl Mater Inter 9:20348–20360. https://doi.org/10.1021/acsami.7b02303CrossRef

Santos T, Fang X, Chen MT, Wang W, Ferreira R, Jhaveri N et al (2014) Sequential administration of carbon nanotubes and near-infrared radiation for the treatment of gliomas. Front Oncol 4:180. https://doi.org/10.3389/fonc.2014.00180CrossRef

Sharifi M, Attar F, Saboury AA, Akhtari K, Hooshmand N, Hasan A et al (2019) Plasmonic gold nanoparticles: optical manipulation, imaging, drug delivery and therapy. J Control Release 311:170–189. https://doi.org/10.1016/j.jconrel.2019.08.032CrossRef

Shi W, Cui XX, Shi JL, Chen J, Wang Y (2017) Overcoming the blood-brain barrier for glioma-targeted therapy based on an interleukin-6 receptor-mediated micelle system. Rsc Adv 7:27162–27169. https://doi.org/10.1039/c7ra03208kCrossRef

Shi YN, Jiang Y, Cao JS, Yang WJ, Zhang J, Meng FH et al (2018a) Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes. J Control Release 292:163–171. https://doi.org/10.1016/j.jconrel.2018.10.034CrossRef

Shi MH, Anantha M, Wehbe M, Bally MB, Fortin D, Roy LO et al (2018) Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats. J Nanobiotechnol 16:77. https://doi.org/10.1186/s12951-018-0404-8CrossRef

Shi XW, Ma R, Lu YP, Cheng Y, Fan XD, Zou JF et al (2020) iRGD and TGN co-modified PAMAM for multi-targeted delivery of ATO to gliomas. Biochem Bioph Res Co 527:117–123. https://doi.org/10.1016/j.bbrc.2020.04.064CrossRef

Singh I, Swami R, Jeengar MK, Khan W, Sistla R (2015) p-Aminophenyl-alpha-D-mannopyranoside engineered lipidic nanoparticles for effective delivery of docetaxel to brain. Chem Phys Lipids 188:1–9. https://doi.org/10.1016/j.chemphyslip.2015.03.003CrossRef

Sonali SRP, Sharma G, Kumari L, Koch B, Singh S et al (2016) RGD-TPGS decorated theranostic liposomes for brain targeted delivery. Colloid Surface B 147:129–141. https://doi.org/10.1016/j.colsurfb.2016.07.058CrossRef

Song PP, Song NN, Li L, Wu MH, Lu ZX, Zhao X (2021) Angiopep-2-Modified Carboxymethyl chitosan-based pH/reduction dual-stimuli-responsive nanogels for enhanced targeting glioblastoma. Biomacromol 22:2921–2934. https://doi.org/10.1021/acs.biomac.1c00314CrossRef

Sonju JJ, Dahal A, Singh SS, Jois SD (2021) Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment. J Control Release 329:624–644. https://doi.org/10.1016/j.jconrel.2020.09.055CrossRef

Su ZG, Xing L, Chen YN, Xu YR, Yang FF, Zhang C et al (2014) Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Mol Pharmaceut 11:1823–1834. https://doi.org/10.1021/mp500238mCrossRef

Su YX, Xie ZW, Kim GB, Dong C, Yang J (2015) Design strategies and applications of circulating cell-mediated drug delivery systems. Acs Biomater Sci Eng 1:201–217. https://doi.org/10.1021/ab500179hCrossRef

Sukumar UK, Bose RJC, Malhotra M, Babikir HA, Afjei R, Robinson E et al (2019) Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide. Biomater 218:119342. https://doi.org/10.1016/j.biomaterials.2019.119342CrossRef

Sun ZL, Yan XB, Liu YB, Huang LS, Kong C, Qu X et al (2017) Application of dual targeting drug delivery system for the improvement of anti-glioma efficacy of doxorubicin. Oncotarget 8:58823–34. https://doi.org/10.18632/oncotarget.19221CrossRef

Suryaprakash S, Lao YH, Cho HY, Li MQ, Ji HY, Shao D et al (2019) Engineered mesenchymal stem cell/nanomedicine spheroid as an active drug delivery platform for combinational glioblastoma therapy. Nano Lett 19:1701–1705. https://doi.org/10.1021/acs.nanolett.8b04697CrossRef

Tammam SN, Azzazy HME, Lamprecht A (2017) The effect of nanoparticle size and NLS density on nuclear targeting in cancer and normal cells; impaired nuclear import and aberrant nanoparticle intracellular trafficking in glioma. Journal of Controlled Release : Official Journal of the Controlled Release Society 253:30–36. https://doi.org/10.1016/j.jconrel.2017.02.029CrossRef

Tian T, Li J, Xie C, Sun YH, Lei HZ, Liu XY et al (2018) Targeted imaging of brain tumors with a framework nucleic acid probe. Acs Appl Mater Inter 10:3414–3420. https://doi.org/10.1021/acsami.7b17927CrossRef

Tomitaka A, Arami H, Gandhi S, Krishnan KM (2015) Lactoferrin conjugated iron oxide nanoparticles for targeting brain glioma cells in magnetic particle imaging. Nanoscale 7:16890–16898. https://doi.org/10.1039/c5nr02831kCrossRef

Torchilin VP (2008a) Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliv Rev 60:548–558. https://doi.org/10.1016/j.addr.2007.10.008CrossRef

Torchilin VP (2008b) Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers 90:604–610. https://doi.org/10.1002/bip.20989CrossRef

Wang YW, Grainger DW (2019) Lyophilized liposome-based parenteral drug development: reviewing complex product design strategies and current regulatory environments. Adv Drug Deliver Rev 151:56–71. https://doi.org/10.1016/j.addr.2019.03.003CrossRef

Wang H, Chen QW, Zhou SQ (2018) Carbon-based hybrid nanogels: a synergistic nanoplatform for combined biosensing, bioimaging, and responsive drug delivery. Chem Soc Rev 47:4198–4232. https://doi.org/10.1039/c7cs00399dCrossRef

Wang H, Xu T, Huang Q, Jin W, Chen J (2020) Immunotherapy for malignant glioma: current status and future directions. Trends Pharmacol Sci 41:123–138. https://doi.org/10.1016/j.tips.2019.12.003CrossRef

Wang HM, Deng H, Gao MH, Zhang WQ (2021) Self-assembled nanogels based on ionic gelation of natural polysaccharides for drug delivery. Front Bioeng Biotech 9:703559. https://doi.org/10.3389/Fbioe.2021.703559CrossRef

Wei L, Guo XY, Yang T, Yu MZ, Chen DW, Wang JC (2016) Brain tumor-targeted therapy by systemic delivery of siRNA with transferrin receptor-mediated core-shell nanoparticles. Int J Pharmaceut 510:394–405. https://doi.org/10.1016/j.ijpharm.2016.06.127CrossRef

Woodman C, Vundu G, George A, Wilson CM (2021) Applications and strategies in nanodiagnosis and nanotherapy in lung cancer. Semin Cancer Biol 69:349–364. https://doi.org/10.1016/j.semcancer.2020.02.009CrossRef

Wu HH, Zhou Y, Tabata Y, Gao JQ (2019) Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic. J Control Release 294:102–113. https://doi.org/10.1016/j.jconrel.2018.12.019CrossRef

Xiang CY, Zhang YX, Guo WS, Liang XJ (2020) Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication. Acta Pharm Sin B 10:239–248. https://doi.org/10.1016/j.apsb.2019.11.003CrossRef

Xiao Y, Cheng L, Xie HJ, Ju RJ, Wang X, Fu M et al (2018) Vinorelbine cationic liposomes modified with wheat germ agglutinin for inhibiting tumor metastasis in treatment of brain glioma. Artif Cell Nanomed B 46:S524–S537. https://doi.org/10.1080/21691401.2018.1501377CrossRef

Xie YD, Han YH, Zhang XF, Ma HW, Li LF, Yu RT, et al. (2021) Application of new radiosensitizer based on nano-biotechnology in the treatment of glioma. Front Oncol 11. Artn 63382710.3389/Fonc.2021.633827

Xiong S, Li ZJ, Liu Y, Wang Q, Luo JS, Chen XJ et al (2020) Brain-targeted delivery shuttled by black phosphorus nanostructure to treat Parkinson’s disease. Biomaterials 260:120339. https://doi.org/10.1016/j.biomaterials.2020.120339CrossRef

Xu ZJ, Wang Y, Ma ZY, Wang ZJ, Wei Y, Jia XR (2016) A poly(amidoamine) dendrimer-based nanocarrier conjugated with Angiopep-2 for dual-targeting function in treating glioma cells. Polym Chem-Uk 7:715–721. https://doi.org/10.1039/c5py01625hCrossRef

Xu YR, Asghar S, Yang L, Li HY, Wang ZL, Ping QN et al (2017) Lactoferrin-coated polysaccharide nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG for treating brain glioma. Carbohyd Polym 157:419–428. https://doi.org/10.1016/j.carbpol.2016.09.085CrossRef

Xu HW, Li CQ, Wei YH, Zheng HS, Zheng HY, Wang BH et al (2021) Angiopep-2-modified calcium arsenite-loaded liposomes for targeted and pH-responsive delivery for anti-glioma therapy. Biochem Bioph Res Co 551:14–20. https://doi.org/10.1016/j.bbrc.2021.02.138CrossRef

Xue JW, Zhao ZK, Zhang L, Xue LJ, Shen SY, Wen YJ et al (2017) Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat Nanotechnol 12:692. https://doi.org/10.1038/Nnano.2017.54CrossRef

Yaghoubi A, Ramazani A (2020) Anticancer DOX delivery system based on CNTs: functionalization, targeting and novel technologies. Journal of Controlled Release : Official Journal of the Controlled Release Society 327:198–224. https://doi.org/10.1016/j.jconrel.2020.08.001CrossRef

Yang ZZ, Du YT, Sun Q, Peng YW, Wang RD, Zhou Y et al (2020a) Albumin-based nanotheranostic probe with hypoxia alleviating potentiates synchronous multimodal imaging and phototherapy for glioma. ACS Nano 14:6191–6212. https://doi.org/10.1021/acsnano.0c02249CrossRef

Yang J, Zhang Q, Liu Y, Zhang X, Shan W, Ye S et al (2020b) Nanoparticle-based co-delivery of siRNA and paclitaxel for dual-targeting of glioblastoma. Nanomedicine (lond) 15:1391–1409. https://doi.org/10.2217/nnm-2020-0066CrossRef

Ying X, Wen H, Lu WL, Du J, Guo J, Tian W et al (2010) Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release 141:183–192. https://doi.org/10.1016/j.jconrel.2009.09.020CrossRef

Yu MA, Su DY, Yang YY, Qin L, Hu C, Liu R et al (2019) D-T7 peptide-modified PEGylated bilirubin nanoparticles loaded with cediranib and paclitaxel for antiangiogenesis and chemotherapy of glioma. Acs Appl Mater Inter 11:176–186. https://doi.org/10.1021/acsami.8b16219CrossRef

Zahednezhad F, Saadat M, Valizadeh H, Zakeri-Milani P, Baradaran B (2019) Liposome and immune system interplay: challenges and potentials. J Control Release 305:194–209. https://doi.org/10.1016/j.jconrel.2019.05.030CrossRef

Zhan WB, Wang CH (2018) Convection enhanced delivery of liposome encapsulated doxorubicin for brain tumour therapy. J Control Release 285:212–229. https://doi.org/10.1016/j.jconrel.2018.07.006CrossRef

Zhang B, Wang H, Liao Z, Wang Y, Hu Y, Yang J et al (2014) EGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma. Biomaterials 35:4133–4145. https://doi.org/10.1016/j.biomaterials.2014.01.071CrossRef

Zhang Y, Zhai MF, Chen ZJ, Han XY, Yu FL, Li ZP et al (2017) Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma. Drug Deliv 24:1045–1055. https://doi.org/10.1080/10717544.2017.1344334CrossRef

Zhang M, Asghar S, Tian CH, Hu ZY, Ping QN, Chen ZP et al (2021) Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma. Carbohyd Polym 253:117194. https://doi.org/10.1016/j.carbpol.2020.117194CrossRef

Zhu YQ, Yu J, Meng FH, Chao D, Ru C, Jian Z et al (2018) Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides. J Control Release 278:1–8. https://doi.org/10.1016/j.jconrel.2018.03.025CrossRef

Zhuang WR, Wang Y, Cui PF, Xing L, Lee J, Kim D et al (2019) Applications of pi-pi stacking interactions in the design of drug-delivery systems. Journal of Controlled Release : Official Journal of the Controlled Release Society 294:311–326. https://doi.org/10.1016/j.jconrel.2018.12.014CrossRef

Zong TL, Mei L, Gao HL, Cai W, Zhu PJ, Shi KR et al (2014) Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals. Mol Pharmaceut 11:2346–2357. https://doi.org/10.1021/mp500057nCrossRef

Zong ZK, Hua L, Wang Z, Xu HY, Ye CK, Pan BM et al (2019) Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy. Drug Deliv 26:34–44. https://doi.org/10.1080/10717544.2018.1534897CrossRef

Titel: Receptor-mediated cascade targeting strategies for the application to medical diagnoses and therapeutics of glioma
verfasst von: Man Liang
Juan Li
Leiqiang Han
Publikationsdatum: 01.06.2022
Verlag: Springer Netherlands
Erschienen in: Journal of Nanoparticle Research / Ausgabe 6/2022
Print ISSN: 1388-0764
Elektronische ISSN: 1572-896X
DOI: https://doi.org/10.1007/s11051-022-05482-8

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht

Springer Professional

Abstract

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Weitere Artikel der Ausgabe 6/2022

Enhanced photocatalytic degradation of Metanil Yellow dye using polypyrrole-based copper oxide–zinc oxide nanocomposites under visible light

SnSe nanoparticles with the ultra-low lattice thermal conductivity: synthesis and characterization

Micelles of Licorice chalcone A for oral administration: preparation, in vitro, in vivo, and hepatoprotective activity evaluation

Composite silicon-iron nanoparticles: physical properties and potential application in MRI contrasting

Thermodynamic modeling of Si–Zn nano-phase diagram including shape effect

Effects of chlorine particle concentration on the human airway

Premium Partner

Marktübersichten